Newsroom

Multiple studies demonstrate the benefit of needle-free vaccination for the prevention and management of Lawsonia intracellularis Additional novel research includes reproductive health, preventive farm care and herd health management MADISON, N.J., May 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of 19 […]

Read more

Novel injectable suspension delivers ongoing efficacy against fleas and ticks for dogs six months and older in a single dose MADISON, N.J., May 1, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved a novel injectable […]

Read more

First vaccine for bovine coronavirus (BCoV), to protect newborn calves against respiratory disease MADISON, NJ, APRIL 4, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the European Commission granted marketing authorization for BOVILIS® Nasalgen®-C, a bovine coronavirus (BCoV) vaccine for cattle. The intranasal, live vaccine can […]

Read more

Virtual event featuring 12 global experts offered free to veterinary professionals MADISON, N.J., March 16, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the company will host a virtual continuing education symposium featuring 12 experts from around the world. This event, sponsored by NOBIVAC® will be […]

Read more

Winning veterinary student sets out to examine canine tick-borne diseases in Nepal MADISON N.J., February 23, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the inaugural recipient of the World Small Animal Veterinary Association (WSAVA) Michael J. Day Scholarship, Somnath Aryal. Aryal, a Nepalese veterinary student […]

Read more

Dutch Minister Micky Adriaansens attends official facility opening Facility capacity to meet increased global customer demand for our innovative vaccines BOXMEER, the Netherlands, Jan. 23, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the opening of a state-of-the-art manufacturing facility in Boxmeer, the Netherlands, for […]

Read more

Innovative single-dose topical treatment proven to safely and effectively treat clinical signs associated with otitis externa in dogs MADISON, N.J., USA, October 24, 2022– MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) issued a […]

Read more

Through its Afya Program, MSD Animal Health Is Committed to the United Against Rabies collaboration’s “Zero by 30” Rabies Elimination Goal MADISON, N.J., Sept. 28, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK), announced on World Rabies Day that it has now donated more than five million […]

Read more

Digital swine traceability solution tracks swine throughout their lifecycle Investment complements MSD Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and technology solutions MADISON, N.J., Sept. 27, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that it has completed a minority investment in LeeO Precision Farming […]

Read more